You could target the aggressor T-cells directly. Or you could target the antigen presenting cell that orchestrates the immune attack." The ultimate goal, Cochrane said, would be a "living ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

The immune system responds to an infection by producing antibodies that recognize and bind to the cell surface of the ...

In the fourth episode of a six-part interview series on immunotherapy, Marc Voigt, CEO and Executive Director of Immutep (ASX ...

High-parameter flow cytometry of peripheral blood mononuclear cells enabled physicians to treat recalcitrant erythroderma in ...

However, it did influence antigen-presenting cells at the injection site. Flu-like symptoms and low-grade injection-site reactions were the common adverse events. No patient had an RCC recurrence ...

The immune system responds to an infection by producing antibodies that recognize and bind to the cell surface of the pathogen, thus marking it as an intruder and triggering an immune response. For ...

Discover how the ALA-CART platform enhances CAR T cell efficacy against antigen-low leukemias. With improved LAT activation, ...

IN8bio (INAB) unveiled INB-600, its next generation gammadelta T cell-based TCE platform. It is designed to address one of the biggest ...